Drug intelligence / Profile preview

PEG-bPEI nanogel

Development stage
Preclinical
Lead developer
University College London
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intraperitoneal
01

Overview

PEG-bPEI nanogel is a non-viral gene delivery platform composed of a polymeric network of polyethylene glycol (PEG) and branched polyethyleneimine (bPEI). Developed by researchers at University College London and the University of Bath, this nanogel system is designed to encapsulate and protect nucleic acids, including plasmid DNA and messenger RNA (mRNA), from enzymatic degradation. The nanogel structure facilitates cellular uptake and intracellular delivery, showing particular efficacy in transfecting difficult-to-reach cell types such as induced pluripotent stem cells (iPSCs) with minimal cytotoxicity. In preclinical studies, it has demonstrated the ability to maintain stable physicochemical properties while enabling measurable gene expression across various cell lines.

Other names
polyethylene glycol-branched polyethyleneimine nanogel
02

Targets

Cell-surface anionic components

Beyond the preview

Go deeper on PEG-bPEI nanogel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PEG-bPEI nanogel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call